<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03654222</url>
  </required_header>
  <id_info>
    <org_study_id>20142018</org_study_id>
    <nct_id>NCT03654222</nct_id>
  </id_info>
  <brief_title>The Long-term Success of Cardiovascular Surgery in Takayasu Arteritis</brief_title>
  <official_title>The Long-term Success of Cardiovascular Surgery in Takayasu Arteritis. 30 Years of Experience in Mexico, Beyond Forefront Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Cardiologia Ignacio Chavez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Cardiologia Ignacio Chavez</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Takayasu Arteritis (TA) affects medium and large caliber arteries causing stenosis, occlusion
      or aneurysms. It has great predilection for the aortic arch, subclavian and extracranial
      arteries. The global prevalence is of 1 to 2% per million inhabitants, which varies by
      geographical region. The main cause of death in TA is of cardiovascular origin and includes
      ischemic cardiomyopathy and valvular disease. The aim of this study was to evaluate the
      surgical experience according to the type of surgery in subjects with TA with and without
      inflammatory activity.

      Methods: This was a retrospective, descriptive, cross-sectional study run between 1977 and
      2017. Patients with Takayasu arteritis with more than 3 classification criteria according to
      the American College of Rheumatology (ACR) were included. The surgeries were classified as:
      Organ preservation, cardiac, bypass, exclusion and replacement. Inflammatory activity was
      evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A review of the clinical records of patients diagnosed with TA with more than 3 criteria of
      the American College of Rheumatology (ACR) and undergoing some surgical procedure by the
      Surgery Service of the National Institute of Cardiology &quot;Ignacio Chávez&quot;, in a period of time
      comprised between 1977 and 2016 was done. Patients of any gender and age who had been
      operated on by a surgical procedure registered in their medical record were included.
      Patients intervened in other institutions were excluded. The surgical event was classified
      into 6 groups: 1) organ-preservation surgery (mainly renal autograft); 2) Bypass
      (revascularization of affected organs or segments with Woven Dacron graft); 3) Replacement
      (replacement of affected aortic segment with a Woven Dacron graft); 4) Cardiac Surgery
      (direct procedures in heart); 5) Exclusion (resection of an affected organ (nephrectomy)),
      and 6) Other.

      Inflammatory activity was evaluated according to the Dabague-Reyes criteria, in which a score
      greater than or equal to 5 is considered as active inflammation (9).

      Statistical analysis: Variables with a loss of the sample data greater than 20% were
      excluded. The categorical variables were described by percentages and prevalences and the
      comparison were done by chi square or Fisher's exact test. A statistically significant level
      was considered when an error α &lt;0.05 was found. Parametric numerical variables are described
      by measures of central tendency and the comparison is made by Student's T test. The survival
      analysis was performed using Kaplan-Meier. Ethical aspects were considered according to the
      Helsinky declaration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 1977</start_date>
  <completion_date type="Actual">June 26, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term survival rate surgery event</measure>
    <time_frame>45 years</time_frame>
    <description>Observed in our study in relation to the mortality associated with the surgical event</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term survival according from other causes</measure>
    <time_frame>30 years</time_frame>
    <description>According to the type of surgery in relation to mortality from other causes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial lesions</measure>
    <time_frame>30 years</time_frame>
    <description>According to Numano's classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory activity</measure>
    <time_frame>30 years</time_frame>
    <description>Evaluated according to the Dabague-Reyes criteria</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">66</enrollment>
  <condition>Arteritis, Takayasu</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery</arm_group_label>
    <description>Direct procedures in heart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Organ preservation</arm_group_label>
    <description>Mainly renal autograft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bypass</arm_group_label>
    <description>Revascularization of affected organs or segments with Woven Dacron graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exclusion</arm_group_label>
    <description>Resection of an affected organ (nephrectomy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Replacement</arm_group_label>
    <description>Replacement of affected aortic segment with a Woven Dacron graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other</arm_group_label>
    <description>Any surgery that does not include the previous ones</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A review of clinical records of patients with diagnosis of Takayasu arteritis and
        undergoing some surgical procedure by the surgery service of the National Institute of
        Cardiology &quot;Ignacio Chávez&quot;, in a period between 1977 and 2016 was conducted.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of any gender regardless of age that has a diagnosis of TA established by a
             rheumatologist,

          -  Have a surgical procedure registered in your medical record

        Exclusion Criteria:

          -  Not having a digital, physical or microfilmed medical record

          -  Surgical procedures performed at another institution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nacional Institute of Cardiology</name>
      <address>
        <city>Mexico City</city>
        <state>Cdmx</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Serra R, Butrico L, Fugetto F, Chibireva MD, Malva A, De Caridi G, Massara M, Barbetta A, Cannistrà M, de Franciscis S. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016 Aug;35:210-25. doi: 10.1016/j.avsg.2016.02.011. Epub 2016 May 27. Review.</citation>
    <PMID>27238990</PMID>
  </reference>
  <reference>
    <citation>Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996 Aug;54 Suppl:S99-102.</citation>
    <PMID>9119532</PMID>
  </reference>
  <reference>
    <citation>Lazzarin P, Pasero G, Marson P, Cecchetto A, Zanchin G. [Takayasu's arteritis. A concise review and some observations on a putative case reported by Giovanni Battista Morgagni (1761)]. Reumatismo. 2005 Dec;57(4):305-13. Italian.</citation>
    <PMID>16380760</PMID>
  </reference>
  <reference>
    <citation>SHIMIZU K, SANO K. Pulseless disease. J Neuropathol Clin Neurol. 1951 Jan;1(1):37-47.</citation>
    <PMID>24538949</PMID>
  </reference>
  <reference>
    <citation>Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996 Aug;54 Suppl:S141-7. Review.</citation>
    <PMID>9119516</PMID>
  </reference>
  <reference>
    <citation>Park SJ, Kim HJ, Park H, Hann HJ, Kim KH, Han S, Kim Y, Ahn HS. Corrigendum to &quot;Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study&quot; [Int. J. Cardiol., 235(2017), 100-104]. Int J Cardiol. 2017 Jul 1;238:182. doi: 10.1016/j.ijcard.2017.04.013. Epub 2017 Apr 24.</citation>
    <PMID>28449826</PMID>
  </reference>
  <reference>
    <citation>Dabague J, Reyes PA. Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. Int J Cardiol. 1996 Aug;54 Suppl:S103-9. Review.</citation>
    <PMID>9119510</PMID>
  </reference>
  <reference>
    <citation>Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S9-15.</citation>
    <PMID>18799047</PMID>
  </reference>
  <reference>
    <citation>Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977 Jan;93(1):94-103.</citation>
    <PMID>12655</PMID>
  </reference>
  <reference>
    <citation>Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013 Aug;88(8):822-30. doi: 10.1016/j.mayocp.2013.04.025. Epub 2013 Jul 10.</citation>
    <PMID>23849994</PMID>
  </reference>
  <reference>
    <citation>Nazareth R, Mason JC. Takayasu arteritis: severe consequences of delayed diagnosis. QJM. 2011 Sep;104(9):797-800. doi: 10.1093/qjmed/hcq193. Epub 2010 Oct 15.</citation>
    <PMID>20952441</PMID>
  </reference>
  <reference>
    <citation>Rosa Neto NS, Shinjo SK, Levy-Neto M, Pereira RMR. Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients. Rheumatol Int. 2017 Jul;37(7):1065-1073. doi: 10.1007/s00296-017-3656-y. Epub 2017 Feb 21.</citation>
    <PMID>28224216</PMID>
  </reference>
  <reference>
    <citation>Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi-Ueda H, Kobayashi J, Yagihara T, Kitamura S. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008 Dec 16;118(25):2738-47. doi: 10.1161/CIRCULATIONAHA.107.759589. Review.</citation>
    <PMID>19106398</PMID>
  </reference>
  <reference>
    <citation>Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. 1978 Jan;57(1):27-35.</citation>
    <PMID>21760</PMID>
  </reference>
  <reference>
    <citation>Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012 Feb 14;125(6):813-9. doi: 10.1161/CIRCULATIONAHA.111.058032. Epub 2012 Jan 9.</citation>
    <PMID>22230484</PMID>
  </reference>
  <reference>
    <citation>Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, Kahn D. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005 Mar;75(3):110-7.</citation>
    <PMID>15777385</PMID>
  </reference>
  <reference>
    <citation>Kaku Y, Aomi S, Tomioka H, Yamazaki K. Surgery for aortic regurgitation and aortic root dilatation in Takayasu arteritis. Asian Cardiovasc Thorac Ann. 2015 Oct;23(8):901-6. doi: 10.1177/0218492315591291. Epub 2015 Jun 18.</citation>
    <PMID>26089524</PMID>
  </reference>
  <reference>
    <citation>Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003 Sep 23;108(12):1474-80. Epub 2003 Sep 2.</citation>
    <PMID>12952846</PMID>
  </reference>
  <reference>
    <citation>Li J, Zhu M, Li M, Zheng W, Zhao J, Tian X, Zeng X. Cause of death in Chinese Takayasu arteritis patients. Medicine (Baltimore). 2016 Jul;95(27):e4069. doi: 10.1097/MD.0000000000004069.</citation>
    <PMID>27399093</PMID>
  </reference>
  <reference>
    <citation>Chiche L, Kieffer E, Sabatier J, Colau A, Koskas F, Bahnini A. Renal autotransplantation for vascular disease: late outcome according to etiology. J Vasc Surg. 2003 Feb;37(2):353-61.</citation>
    <PMID>12563206</PMID>
  </reference>
  <results_reference>
    <citation>Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010 Jan;56(1):3-23. doi: 10.1111/j.1365-2559.2009.03443.x. Review.</citation>
    <PMID>20055902</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>August 29, 2018</last_update_submitted>
  <last_update_submitted_qc>August 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Cardiologia Ignacio Chavez</investigator_affiliation>
    <investigator_full_name>Maria Elena Soto, MsC and PhD</investigator_full_name>
    <investigator_title>RESEARCH DOCTOR</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

